Is VALN or VYGR more undervalued in 2026?

CirclFi compares Valneva SE (VALN) and Voyager Therapeutics, Inc. (VYGR) using 13 institutional-grade valuation models. VALN has a Quality of Company score of 5.3/10 while VYGR scores 5.6/10.

Which is a better buy — VALN or VYGR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do VALN and VYGR valuations compare?

VALN at $6.25 and VYGR at $3.87 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

VALN vs VYGR Valuation Comparison 2026 — Intrinsic Value Analysis

VALN

Biological Products, (No Diagnostic Substances)

Valneva SE

Quality

5.3

out of 10

Value Trap

LOW

Price

$6.25

Last close

Models

11/13

Active

VYGR

Biological Products, (No Diagnostic Substances)

Voyager Therapeutics, Inc.

Quality

5.6

out of 10

Value Trap

LOW

Price

$3.87

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	VALN Fair Value	VALN Upside	VYGR Fair Value	VYGR Upside
Bayesian DCF	Intrinsic	$1.29	-79.4%	$0.93	-75.9%
Earnings Power Value	Intrinsic	$2.37	-55.7%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.25	-96.0%	$3.21	-17.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for VALN vs VYGR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VALN vs VYGR — Which Stock Is More Undervalued?

VYGR scores higher with a 5.6/10 quality rating vs VALN's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Valneva SE (VALN) and Voyager Therapeutics, Inc. (VYGR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VALN currently trades at $6.25 with a QOC of 5.3/10, while VYGR trades at $3.87 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).